Experimental Aristolochic Acid Nephropathy: A Relevant Model to Study AKI-to-CKD Transition

Thomas Baudoux, Inès Jadot, Anne Emilie Declèves, Marie Hélène Antoine, Jean Marie Colet, Olivia Botton, Eric De Prez, Agnieszka Pozdzik, Cécile Husson, Nathalie Caron, Joëlle L. Nortier

Résultats de recherche: Contribution à un journal/une revueArticle de revueRevue par des pairs

12 Téléchargements (Pure)


Aristolochic acid nephropathy (AAN) is a progressive tubulointerstitial nephritis caused by the intake of aristolochic acids (AA) contained in Chinese herbal remedies or contaminated food. AAN is characterized by tubular atrophy and interstitial fibrosis, characterizing advanced kidney disease. It is established that sustained or recurrent acute kidney injury (AKI) episodes contribute to the progression of CKD. Therefore, the study of underlying mechanisms of AA-induced nephrotoxicity could be useful in understanding the complex AKI-to-CKD transition. We developed a translational approach of AKI-to-CKD transition by reproducing human AAN in rodent models. Indeed, in such models, an early phase of acute tubular necrosis was rapidly followed by a massive interstitial recruitment of activated monocytes/macrophages followed by cytotoxic T lymphocytes, resulting in a transient AKI episode. A later chronic phase was then observed with progressive tubular atrophy related to dedifferentiation and necrosis of tubular epithelial cells. The accumulation of vimentin and αSMA-positive cells expressing TGFβ in interstitial areas suggested an increase in resident fibroblasts and their activation into myofibroblasts resulting in collagen deposition and CKD. In addition, we identified 4 major actors in the AKI-to-CKD transition: (1) the tubular epithelial cells, (2) the endothelial cells of the interstitial capillary network, (3) the inflammatory infiltrate, and (4) the myofibroblasts. This review provides the most comprehensive and informative data we were able to collect and examines the pending questions.

langue originaleAnglais
Numéro d'article822870
journalFrontiers in Medicine
Les DOIs
Etat de la publicationPublié - 4 mai 2022

Contient cette citation